Moderna (MRNA) Stock Highlights

69.46 | -0.57%

2024-09-19 16:32:03

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firms mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Statistics

Range Today

69.35 71.97

Volume Today 1.79M

Range 1 Year

62.55 170.47

Volume 1 Year 1.09B

Range 3 Year

62.55 458.5

Volume 3 Year 4.21B

Range 10 Year

11.54 497.49

Volume 10 Year 11.74B

Highlights

Market Capitalization 26.25B (large)

Floating Shares 347.11M

Current Price 69.46

Price To Earnings -4.31

Price To Revenue 3.77

Price To Book 2.24

Earnings Per Share -15.35

Payout Ratio 0%

Performance

Latest -0.57%

1 Month -20.18%

3 Months -47.59%

6 Months -33.15%

1 Year -32.11%

3 Years -83.36%

5 Years +292.21%

10 Years +215.73%

Benchmarks

Market Capitalization

4 / 368

Gross Profits

1 / 278

Total Revenue

3 / 300

Total Rank

1 / 368

Free Cashflow

351 / 352

Performance 5 years

24 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.